{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:16:33Z","timestamp":1789787793594,"version":"4.0.1"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome trust","doi-asserted-by":"publisher","award":["103406\/Z\/13\/Z"],"award-info":[{"award-number":["103406\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","award":["MR\/M006824"],"award-info":[{"award-number":["MR\/M006824"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:p>The efficacy of anticholinesterase medication may diminish over time. Vanhaesebrouck et al. use an animal model of acetylcholine receptor deficiency syndrome to show that beta-2 adrenergic receptor agonists ameliorate the damage to neuromuscular junction structure caused by prolonged anticholinesterase medication, and thereby counteract the decline in efficacy.<\/jats:p>","DOI":"10.1093\/brain\/awz322","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T19:26:43Z","timestamp":1569958003000},"page":"3713-3727","source":"Crossref","is-referenced-by-count":44,"title":["\u03b22-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure"],"prefix":"10.1093","volume":"142","author":[{"given":"An E","family":"Vanhaesebrouck","sequence":"first","affiliation":[{"name":"Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Webster","sequence":"additional","affiliation":[{"name":"Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Maxwell","sequence":"additional","affiliation":[{"name":"Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro M","family":"Rodriguez Cruz","sequence":"additional","affiliation":[{"name":"Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DS, UK"},{"name":"Department of Clinical Neurology, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Cossins","sequence":"additional","affiliation":[{"name":"Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Wickens","sequence":"additional","affiliation":[{"name":"Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, OX1 3TA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Cetin","sequence":"additional","affiliation":[{"name":"Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cheung","sequence":"additional","affiliation":[{"name":"Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Ramjattan","sequence":"additional","affiliation":[{"name":"Paediatric Neurology, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurology, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-7132","authenticated-orcid":false,"given":"David","family":"Beeson","sequence":"additional","affiliation":[{"name":"Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"2019121205073682800_awz322-B1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2015.10.006","article-title":"beta(2)-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)","volume":"85","author":"Bartus","year":"2016","journal-title":"Neurobiol Dis"},{"key":"2019121205073682800_awz322-B2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/WCO.0000000000000370","article-title":"Congenital myasthenic syndromes: recent advances","volume":"29","author":"Beeson","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"2019121205073682800_awz322-B3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00415-009-5405-y","article-title":"Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7","volume":"257","author":"Ben Ammar","year":"2010","journal-title":"J Neurol"},{"key":"2019121205073682800_awz322-B4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020490","article-title":"Fundamental molecules and mechanisms for forming and maintaining neuromuscular synapses","volume":"19","author":"Burden","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2019121205073682800_awz322-B5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature03479","article-title":"X-inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"2019121205073682800_awz322-B6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1113\/jphysiol.1973.sp010207","article-title":"Influence of chronic neostigmine treatment on the number of acetylcholine receptors and the release of acetylcholine from the rat diaphragm","volume":"230","author":"Chang","year":"1973","journal-title":"J Physiol"},{"key":"2019121205073682800_awz322-B7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1476-5381.1986.tb14594.x","article-title":"Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm","volume":"87","author":"Chang","year":"1986","journal-title":"Br J Pharmacol"},{"key":"2019121205073682800_awz322-B8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5414\/CPP47413","article-title":"Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers","volume":"47","author":"Chik","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2019121205073682800_awz322-B9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JND-170293","article-title":"Beta-2 adrenergic receptor agonists enhance AChR clustering in C2C12 myotubes: implications for therapy of myasthenic disorders","volume":"5","author":"Clausen","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"2019121205073682800_awz322-B10","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/hmg\/ddh320","article-title":"A mouse model of AChR deficiency syndrome with a phenotype reflecting the human condition","volume":"13","author":"Cossins","year":"2004","journal-title":"Hum Mol Genet"},{"key":"2019121205073682800_awz322-B11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","article-title":"The therapy of congenital myasthenic syndromes","volume":"4","author":"Engel","year":"2007","journal-title":"Neurotherapeutics"},{"key":"2019121205073682800_awz322-B12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/med\/9780199738670.003.0006","volume-title":"Myasthenia Gravis and Myasthenic Disorders","author":"Drachman","year":"2012"},{"key":"2019121205073682800_awz322-B13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11910-018-0852-4","article-title":"Congenital Myasthenic Syndromes in 2018","volume":"18","author":"Engel","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2019121205073682800_awz322-B14","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.23.12.1273","article-title":"Study of long-term anticholinesterase therapy - effects on neuromuscular-transmission and on motor endplate fine-structure","volume":"23","author":"Engel","year":"1973","journal-title":"Neurology"},{"key":"2019121205073682800_awz322-B15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.1971.tb30741.x","article-title":"Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome","volume":"183","author":"Engel","year":"1971","journal-title":"Ann N Y Acad Sci"},{"key":"2019121205073682800_awz322-B16","first-page":"271","article-title":"Effects of neostigmine and pyridostigmine at the neuromuscular junction","volume":"14","author":"Gillies","year":"1977","journal-title":"Clin Exp Neurol"},{"key":"2019121205073682800_awz322-B17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnagi.2014.00208","article-title":"The neuromuscular junction: aging at the crossroad between nerves and muscle","volume":"6","author":"Gonzalez-Freire","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"2019121205073682800_awz322-B18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0896-6273(90)90305-Y","article-title":"Properties of embryonic and adult muscle acetylcholine receptors transiently expressed in COS cells","volume":"5","author":"Gu","year":"1990","journal-title":"Neuron"},{"key":"2019121205073682800_awz322-B19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/314164a0","article-title":"Firing patterns of motor units in normal rats","volume":"314","author":"Hennig","year":"1985","journal-title":"Nature"},{"key":"2019121205073682800_awz322-B20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"2019121205073682800_awz322-B21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1113\/jphysiol.1957.sp005811","article-title":"On the factors which determine the amplitude of the miniature end-plate potential","volume":"137","author":"Katz","year":"1957","journal-title":"J Physiol"},{"key":"2019121205073682800_awz322-B22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1073\/pnas.1524272113","article-title":"Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease","volume":"113","author":"Khan","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019121205073682800_awz322-B23","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1128\/MCB.25.13.5329-5338.2005","article-title":"Inhibition of MuSK expression by CREB interacting with a CRE-like element and MyoD","volume":"25","author":"Kim","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2019121205073682800_awz322-B24","first-page":"277","article-title":"A new method for the measurement of muscle relaxation in white mice","volume":"152","author":"Kondziella","year":"1964","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"2019121205073682800_awz322-B25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135 (Pt 4)","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"2019121205073682800_awz322-B26","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1074\/jbc.M507502200","article-title":"Acetylcholinesterase dynamics at the neuromuscular junction of live animals","volume":"281","author":"Krejci","year":"2006","journal-title":"J Biol Chem"},{"key":"2019121205073682800_awz322-B27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2005.12.003","article-title":"Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost","volume":"16","author":"Kummer","year":"2006","journal-title":"Curr Opin Neurobiol"},{"key":"2019121205073682800_awz322-B28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.expneurol.2015.02.025","article-title":"Guidelines for pre-clinical assessment of the acetylcholine receptor\u2013specific passive transfer myasthenia gravis model-Recommendations for methods and experimental designs","volume":"270","author":"Kusner","year":"2015","journal-title":"Exp Neurol"},{"key":"2019121205073682800_awz322-B29","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7","volume":"74","author":"Lashley","year":"2010","journal-title":"Neurol"},{"key":"2019121205073682800_awz322-B30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/mus.22176","article-title":"Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia","volume":"44","author":"Liewluck","year":"2011","journal-title":"Muscle Nerve"},{"key":"2019121205073682800_awz322-B31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuron.2005.04.002","article-title":"Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism","volume":"46","author":"Lin","year":"2005","journal-title":"Neuron"},{"key":"2019121205073682800_awz322-B32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1113\/jphysiol.1978.sp012438","article-title":"A voltage-clamp study of the permeability change induced by quanta of transmitter at the mouse end-plate","volume":"281","author":"Linder","year":"1978","journal-title":"J Physiol"},{"key":"2019121205073682800_awz322-B33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nmd.2016.11.009","article-title":"Ephedrine treatment for autoimmune myasthenia gravis","volume":"27","author":"Lipka","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"2019121205073682800_awz322-B34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1152\/physrev.00028.2007","article-title":"Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease","volume":"88","author":"Lynch","year":"2008","journal-title":"Physiol Rev"},{"key":"2019121205073682800_awz322-B35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1113\/jphysiol.1981.sp013586","article-title":"Non-linear summation of end-plate potentials in the frog and mouse","author":"McLachlan","year":"1981","journal-title":"J Physiol"},{"key":"2019121205073682800_awz322-B36","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/hmg\/ddy062","article-title":"The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes","volume":"27","author":"McMacken","year":"2018","journal-title":"Hum Mol Genet"},{"key":"2019121205073682800_awz322-B37","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddz059","article-title":"Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome","author":"McMacken","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2019121205073682800_awz322-B38","first-page":"CD006986","article-title":"Acetylcholinesterase inhibitor treatment for myasthenia gravis","volume":"10","author":"Mehndiratta","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2019121205073682800_awz322-B39","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1242\/dev.124.24.5075","article-title":"Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an \u2018adult\u2019 acetylcholine receptor subunit","volume":"124","author":"Missias","year":"1997","journal-title":"Development"},{"key":"2019121205073682800_awz322-B40","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","article-title":"Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody","volume":"591 (Pt 10)","author":"Morsch","year":"2013","journal-title":"J Physiol"},{"key":"2019121205073682800_awz322-B41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Arch Dis Child"},{"key":"2019121205073682800_awz322-B42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1083\/jcb.145.4.911","article-title":"Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan","volume":"145","author":"Peng","year":"1999","journal-title":"J Cell Biol"},{"key":"2019121205073682800_awz322-B43","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.nmd.2018.07.013","article-title":"Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy?","volume":"28","author":"Pera","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2019121205073682800_awz322-B44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.expneurol.2015.01.007","article-title":"Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models","volume":"270","author":"Plomp","year":"2015","journal-title":"Exp Neurol"},{"key":"2019121205073682800_awz322-B45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1113\/jphysiol.1992.sp019429","article-title":"Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats","volume":"458","author":"Plomp","year":"1992","journal-title":"J Physiol"},{"key":"2019121205073682800_awz322-B46","first-page":"1043","article-title":"The sympathetic nervous system regulates skeletal muscle motor innervation and acetylcholine receptor stability","volume":"85","author":"Rodrigues","year":"2015","journal-title":"Acta Physiol (Oxf)"},{"key":"2019121205073682800_awz322-B47","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1212\/WNL.0000000000001952","article-title":"Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes","volume":"85","author":"Rodriguez Cruz","year":"2015","journal-title":"Neurology"},{"key":"2019121205073682800_awz322-B48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.22153","article-title":"Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations","volume":"44","author":"Sadeh","year":"2011","journal-title":"Muscle Nerve"},{"key":"2019121205073682800_awz322-B49","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.clinph.2013.11.007","article-title":"Is the decremental pattern in Lambert-Eaton syndrome different from that in myasthenia gravis?","volume":"125","author":"Sanders","year":"2014","journal-title":"Clin Neurophysiol"},{"key":"2019121205073682800_awz322-B50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.nmd.2009.09.008","article-title":"Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations","volume":"19","author":"Schara","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"2019121205073682800_awz322-B51","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"2019121205073682800_awz322-B52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/HYPERTENSIONAHA.116.08507","article-title":"Overexpression of sarcoendoplasmic reticulum calcium ATPase 2a promotes cardiac sympathetic neurotransmission via abnormal endoplasmic reticulum and mitochondria Ca2+ regulation","volume":"69","author":"Shanks","year":"2017","journal-title":"Hypertension"},{"key":"2019121205073682800_awz322-B53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s004390000359","article-title":"Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations","volume":"107","author":"Sieb","year":"2000","journal-title":"Hum Genet"},{"key":"2019121205073682800_awz322-B54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102183","article-title":"The structure of human neuromuscular junctions: some unanswered molecular questions","volume":"18","author":"Slater","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2019121205073682800_awz322-B55","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2008.09.033","article-title":"Terbutaline in myasthenia gravis: a pilot study","volume":"277","author":"Soliven","year":"2009","journal-title":"J Neurol Sci"},{"key":"2019121205073682800_awz322-B56","first-page":"326","article-title":"Neostigmine-induced alterations at mammalian neuromuscular-junction. 1. Muscle-contraction and electrophysiology","volume":"205","author":"Tiedt","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"2019121205073682800_awz322-B57","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archneur.1975.00490540052006","article-title":"Neostigmine methylsulfate. Does it have a chronic effect as well as a transient one?","volume":"32","author":"Ward","year":"1975","journal-title":"Arch Neurol"},{"key":"2019121205073682800_awz322-B58","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2013.06.012","article-title":"A mouse model of the slow channel myasthenic syndrome: neuromuscular physiology and effects of ephedrine treatment","volume":"248","author":"Webster","year":"2013","journal-title":"Exp Neurol"},{"key":"2019121205073682800_awz322-B59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1113\/jphysiol.1997.sp022007","article-title":"The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles","volume":"500 (Pt 1)","author":"Wood","year":"1997","journal-title":"J Physiol"},{"key":"2019121205073682800_awz322-B60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction","volume":"64","author":"Wood","year":"2001","journal-title":"Progr Neurobiol"},{"key":"2019121205073682800_awz322-B61","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/brain\/aww070","article-title":"Mice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis","volume":"139 (Pt 6)","author":"Wu","year":"2016","journal-title":"Brain"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/142\/12\/3713\/31499540\/awz322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/142\/12\/3713\/31499540\/awz322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T19:07:57Z","timestamp":1664564877000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/142\/12\/3713\/5601472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":61,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,10,21]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awz322","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,10,21]]}}}